A study of data from pre and post-cannabis legalisation in Canada has found no increase in admissions to hospitals for cannabis-related episodes of psychosis. The relationship between cannabis use and episodes of psychosis is a contentious issue that is often raised by opponents of legalisation. Results [...]
Via Business of Cannabis Spain’s Ministry of Health has launched a public consultation on its proposals for a medical cannabis framework in the country. Organisations and individual citizens will now have until 4 March to submit their comments on the proposals, as Spain’s new government makes [...]
Back in 2020, the European Commission formally classified edible cannabidiol (CBD) products like gummies, drinks, oils and even bread as novel foods (NFs). Today, all submitted applications remain on hold, with no CBD products receiving NF authorisation in the UK or Europe. Here Libby Clarke, managing [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.